Cite
Retro-inverso follicle-stimulating hormone peptide-mediated polyethylenimine complexes for targeted ovarian cancer gene therapy.
MLA
Zhang, Mengyu, et al. “Retro-Inverso Follicle-Stimulating Hormone Peptide-Mediated Polyethylenimine Complexes for Targeted Ovarian Cancer Gene Therapy.” Drug Delivery, vol. 25, no. 1, Jan. 2018, pp. 995–1003. EBSCOhost, https://doi.org/10.1080/10717544.2018.1461956.
APA
Zhang, M., Zhang, M., Wang, J., Cai, Q., Zhao, R., Yu, Y., Tai, H., Zhang, X., & Xu, C. (2018). Retro-inverso follicle-stimulating hormone peptide-mediated polyethylenimine complexes for targeted ovarian cancer gene therapy. Drug Delivery, 25(1), 995–1003. https://doi.org/10.1080/10717544.2018.1461956
Chicago
Zhang, Mengyu, Mingxing Zhang, Jing Wang, Qingqing Cai, Ran Zhao, Yi Yu, Haiyan Tai, Xiaoyan Zhang, and Congjian Xu. 2018. “Retro-Inverso Follicle-Stimulating Hormone Peptide-Mediated Polyethylenimine Complexes for Targeted Ovarian Cancer Gene Therapy.” Drug Delivery 25 (1): 995–1003. doi:10.1080/10717544.2018.1461956.